| |
Research Summary
I am interested in the pharmacokinetics of polymeric drug delivery vehicles and controlled release rates of drugs from drug delivery vehicles by using the MRI contrast ag
ents. Lanthanide chelates will be conjugated to polymeric systems to measure the rate of tumor accumulation. In addition, "smart" lanthanide chelates will be incorporated into the
drug-polymer covalent linker, which can be detected via CEST MRI only after the drug is detached from the polymeric system. CEST MRI methods will be developed to monitor both types of lant
hanide chelates to independently monitor the rate of tumor accumulation and the rate of drug release.
Recent Publications
| |
Liu G, Li Y, Pagel MD. Design and characterization of new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Magn. Reson. Med., 2007, 5
8:1249-1256. |
| |
|